Centogene N.v. buy krebskrebs
Start price
27.07.20
/
50%
€11.90
Target price
04.11.21
€20.00
Performance (%)
-31.43%
End price
05.11.21
€8.16
Summary
This prediction ended on 05.11.21 with a price of €8.16. The BUY prediction by krebskrebs for Centogene N.v. performed very badly with a performance of -31.43%. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Centogene N.v. | - | - | - | - |
| iShares Core DAX® | 2.489% | -5.941% | 2.896% | 45.717% |
| iShares Nasdaq 100 | 1.649% | -2.462% | 15.754% | 73.262% |
| iShares Nikkei 225® | 0.555% | -7.597% | 30.353% | 48.769% |
| iShares S&P 500 | 1.347% | -2.943% | 10.338% | 55.803% |
Comments by krebskrebs for this prediction
In the thread Centogene N.v. diskutieren
Buy mit Kursziel 20,0
In the thread Trading Centogene N.v.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten